APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hib Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hib Vaccine Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchHib Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Hib Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hib Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hib Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hib Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Hib Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hib Vaccine include Lanzhou Institute, Zhifei Bio, Sanofi Pasteur, Kangtai Bio, Watson Bio, Glaxosmithkline, Olin Bio and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hib Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hib Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hib Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hib Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hib Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hib Vaccine Market by Company

Lanzhou Institute

Zhifei Bio

Sanofi Pasteur

Kangtai Bio

Watson Bio

Glaxosmithkline

Olin Bio

Bharat Biotech

Hib Vaccine Segment by Type

Hib Vaccine

Multiple Seedlings

Hib Vaccine Segment by Application

Hospital

Clinic

Hib Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hib Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hib Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hib Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hib Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hib Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hib Vaccine Table 2. Major Company of Multiple Seedlings Table 3. Global Hib Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hib Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Hib Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hib Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hib Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Hib Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Hib Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Hib Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hib Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hib Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Hib Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Hib Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Hib Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hib Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Hib Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hib Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Hib Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hib Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Hib Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hib Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Hib Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Hib Vaccine Industry Trends Table 25. Hib Vaccine Industry Drivers Table 26. Hib Vaccine Industry Opportunities and Challenges Table 27. Hib Vaccine Industry Restraints Table 28. Global Hib Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hib Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Hib Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Hib Vaccine Sales Share by Company (2021-2026) Table 32. Global Hib Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Hib Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hib Vaccine Major Company Production Sites and Headquarters Table 35. Global Hib Vaccine Company, Product Type & Application Table 36. Global Hib Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hib Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hib Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hib Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Hib Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hib Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hib Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Hib Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Hib Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hib Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hib Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Hib Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Hib Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hib Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Hib Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hib Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hib Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Hib Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Hib Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Hib Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hib Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hib Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Hib Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Hib Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Hib Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hib Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Hib Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hib Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Hib Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hib Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Hib Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hib Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Hib Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Lanzhou Institute Company Information Table 72. Lanzhou Institute Business Overview Table 73. Lanzhou Institute Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Lanzhou Institute Hib Vaccine Product Portfolio Table 75. Lanzhou Institute Recent Development Table 76. Zhifei Bio Company Information Table 77. Zhifei Bio Business Overview Table 78. Zhifei Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Zhifei Bio Hib Vaccine Product Portfolio Table 80. Zhifei Bio Recent Development Table 81. Sanofi Pasteur Company Information Table 82. Sanofi Pasteur Business Overview Table 83. Sanofi Pasteur Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur Hib Vaccine Product Portfolio Table 85. Sanofi Pasteur Recent Development Table 86. Kangtai Bio Company Information Table 87. Kangtai Bio Business Overview Table 88. Kangtai Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Kangtai Bio Hib Vaccine Product Portfolio Table 90. Kangtai Bio Recent Development Table 91. Watson Bio Company Information Table 92. Watson Bio Business Overview Table 93. Watson Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Watson Bio Hib Vaccine Product Portfolio Table 95. Watson Bio Recent Development Table 96. Glaxosmithkline Company Information Table 97. Glaxosmithkline Business Overview Table 98. Glaxosmithkline Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Glaxosmithkline Hib Vaccine Product Portfolio Table 100. Glaxosmithkline Recent Development Table 101. Olin Bio Company Information Table 102. Olin Bio Business Overview Table 103. Olin Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Olin Bio Hib Vaccine Product Portfolio Table 105. Olin Bio Recent Development Table 106. Bharat Biotech Company Information Table 107. Bharat Biotech Business Overview Table 108. Bharat Biotech Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bharat Biotech Hib Vaccine Product Portfolio Table 110. Bharat Biotech Recent Development Table 111. North America Hib Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. North America Hib Vaccine Sales by Country (2021-2026) & (k units) Table 113. North America Hib Vaccine Sales Market Share by Country (2021-2026) Table 114. North America Hib Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 115. North America Hib Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. North America Hib Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Hib Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Hib Vaccine Market Share by Country (2021-2026) Table 119. North America Hib Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Hib Vaccine Market Share Forecast by Country (2027-2032) Table 121. Europe Hib Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Europe Hib Vaccine Sales by Country (2021-2026) & (k units) Table 123. Europe Hib Vaccine Sales Market Share by Country (2021-2026) Table 124. Europe Hib Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 125. Europe Hib Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Hib Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Hib Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Hib Vaccine Market Share by Country (2021-2026) Table 129. Europe Hib Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Hib Vaccine Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Hib Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Hib Vaccine Sales by Country (2021-2026) & (k units) Table 133. Asia-Pacific Hib Vaccine Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Hib Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 135. Asia-Pacific Hib Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Hib Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Hib Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Hib Vaccine Market Share by Country (2021-2026) Table 139. Asia-Pacific Hib Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Hib Vaccine Market Share Forecast by Country (2027-2032) Table 141. Latin America Hib Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Latin America Hib Vaccine Sales by Country (2021-2026) & (k units) Table 143. Latin America Hib Vaccine Sales Market Share by Country (2021-2026) Table 144. Latin America Hib Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 145. Latin America Hib Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Hib Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Hib Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Hib Vaccine Market Share by Country (2021-2026) Table 149. Latin America Hib Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Hib Vaccine Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Hib Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Hib Vaccine Sales by Country (2021-2026) & (k units) Table 153. Middle East and Africa Hib Vaccine Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Hib Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 155. Middle East and Africa Hib Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Hib Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Hib Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Hib Vaccine Market Share by Country (2021-2026) Table 159. Middle East and Africa Hib Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Hib Vaccine Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Hib Vaccine Distributors List Table 164. Hib Vaccine Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Hib Vaccine Image Figure 2. Global Hib Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hib Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hib Vaccine Sales (2021-2032) & (k units) Figure 5. Hib Vaccine Image Figure 6. Global Hib Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Multiple Seedlings Image Figure 8. Global Multiple Seedlings Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Hib Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hib Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Hib Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Hib Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Hib Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hib Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hib Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hib Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hib Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hib Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hib Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hib Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hib Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Hib Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Hib Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Hib Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Hib Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Hib Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Hib Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Hib Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Hib Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Hib Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Hib Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Hib Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Hib Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Hib Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Hib Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Hib Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Hib Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hib Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hib Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Hib Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hib Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Hib Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Hib Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hib Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Hib Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Hib Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Hib Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hib Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Hib Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Hib Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Hib Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Hib Vaccine
  • Multiple Seedlings
Applications
  • Hospital
  • Clinic
Companies covered
  • Lanzhou Institute
  • Zhifei Bio
  • Sanofi Pasteur
  • Kangtai Bio
  • Watson Bio
  • Glaxosmithkline
  • Olin Bio
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hib Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hib Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hib Vaccine Market by Type
  6. 1.3.1 Hib Vaccine
  7. 1.3.2 Multiple Seedlings
  8. 1.4 Global Hib Vaccine Market Size by Type
  9. 1.4.1 Global Hib Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hib Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hib Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hib Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hib Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hib Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hib Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hib Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hib Vaccine Industry Trends
  2. 2.2 Hib Vaccine Industry Drivers
  3. 2.3 Hib Vaccine Industry Opportunities and Challenges
  4. 2.4 Hib Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hib Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Hib Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Hib Vaccine Price (2021-2026)
  4. 3.4 Global Hib Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hib Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Hib Vaccine Company, Product Type & Application
  7. 3.7 Global Hib Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hib Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hib Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hib Vaccine Tier 1, Tier 2, and Tier 3
4 Hib Vaccine Regional Status and Outlook
  1. 4.1 Global Hib Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hib Vaccine Historic Market Size by Region
  3. 4.2.1 Global Hib Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hib Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hib Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hib Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Hib Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hib Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hib Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hib Vaccine by Application
  1. 5.1 Hib Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Hib Vaccine Market Size by Application
  5. 5.2.1 Global Hib Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hib Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hib Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hib Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hib Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hib Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hib Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hib Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Lanzhou Institute
  2. 6.1.1 Lanzhou Institute Company Information
  3. 6.1.2 Lanzhou Institute Business Overview
  4. 6.1.3 Lanzhou Institute Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Lanzhou Institute Hib Vaccine Product Portfolio
  6. 6.1.5 Lanzhou Institute Recent Developments
  7. 6.2 Zhifei Bio
  8. 6.2.1 Zhifei Bio Company Information
  9. 6.2.2 Zhifei Bio Business Overview
  10. 6.2.3 Zhifei Bio Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhifei Bio Hib Vaccine Product Portfolio
  12. 6.2.5 Zhifei Bio Recent Developments
  13. 6.3 Sanofi Pasteur
  14. 6.3.1 Sanofi Pasteur Company Information
  15. 6.3.2 Sanofi Pasteur Business Overview
  16. 6.3.3 Sanofi Pasteur Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Pasteur Hib Vaccine Product Portfolio
  18. 6.3.5 Sanofi Pasteur Recent Developments
  19. 6.4 Kangtai Bio
  20. 6.4.1 Kangtai Bio Company Information
  21. 6.4.2 Kangtai Bio Business Overview
  22. 6.4.3 Kangtai Bio Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kangtai Bio Hib Vaccine Product Portfolio
  24. 6.4.5 Kangtai Bio Recent Developments
  25. 6.5 Watson Bio
  26. 6.5.1 Watson Bio Company Information
  27. 6.5.2 Watson Bio Business Overview
  28. 6.5.3 Watson Bio Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Watson Bio Hib Vaccine Product Portfolio
  30. 6.5.5 Watson Bio Recent Developments
  31. 6.6 Glaxosmithkline
  32. 6.6.1 Glaxosmithkline Company Information
  33. 6.6.2 Glaxosmithkline Business Overview
  34. 6.6.3 Glaxosmithkline Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Glaxosmithkline Hib Vaccine Product Portfolio
  36. 6.6.5 Glaxosmithkline Recent Developments
  37. 6.7 Olin Bio
  38. 6.7.1 Olin Bio Company Information
  39. 6.7.2 Olin Bio Business Overview
  40. 6.7.3 Olin Bio Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Olin Bio Hib Vaccine Product Portfolio
  42. 6.7.5 Olin Bio Recent Developments
  43. 6.8 Bharat Biotech
  44. 6.8.1 Bharat Biotech Company Information
  45. 6.8.2 Bharat Biotech Business Overview
  46. 6.8.3 Bharat Biotech Hib Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bharat Biotech Hib Vaccine Product Portfolio
  48. 6.8.5 Bharat Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Hib Vaccine Sales by Country
  2. 7.1.1 North America Hib Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hib Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Hib Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hib Vaccine Market Size by Country
  6. 7.2.1 North America Hib Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hib Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Hib Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hib Vaccine Sales by Country
  2. 8.1.1 Europe Hib Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hib Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Hib Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hib Vaccine Market Size by Country
  6. 8.2.1 Europe Hib Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hib Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hib Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hib Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Hib Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hib Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hib Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hib Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Hib Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hib Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hib Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hib Vaccine Sales by Country
  2. 10.1.1 South America Hib Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hib Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Hib Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hib Vaccine Market Size by Country
  6. 10.2.1 South America Hib Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hib Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Hib Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hib Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Hib Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hib Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hib Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hib Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Hib Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hib Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hib Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hib Vaccine Value Chain Analysis
  2. 12.1.1 Hib Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hib Vaccine Production Mode & Process
  7. 12.2 Hib Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hib Vaccine Distributors
  10. 12.2.3 Hib Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst